These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 12073810)

  • 1. Cardiac surgery in an era of antiplatelet therapies: generating new evidence.
    Ley SJ
    Reflect Nurs Leadersh; 2002; 28(2):35. PubMed ID: 12073810
    [No Abstract]   [Full Text] [Related]  

  • 2. Differences between ACC/AHA and ESC Guidelines on antiplatelet therapy in patients with acute coronary syndromes.
    Huber K; Lip GY
    Thromb Haemost; 2013 Jul; 110(1):11-3. PubMed ID: 23743615
    [No Abstract]   [Full Text] [Related]  

  • 3. [Plavix--medicine of the year 2003].
    Fehér J
    Orv Hetil; 2004 Jun; 145(24):1303. PubMed ID: 15264761
    [No Abstract]   [Full Text] [Related]  

  • 4. Aspirin + clopidogrel therapy: how does your care compare to the evidence?
    Simmons BB; Salzman BE
    J Fam Pract; 2008 Jan; 57(1):26-32. PubMed ID: 18171566
    [No Abstract]   [Full Text] [Related]  

  • 5. Improving outcomes with antiplatelet therapies in percutaneous coronary intervention and stenting.
    Hobson A; Curzen N
    Thromb Haemost; 2009 Jan; 101(1):23-30. PubMed ID: 19132185
    [No Abstract]   [Full Text] [Related]  

  • 6. Clopidogrel in atrial fibrillation: is there any justification now in the era of new anticoagulants?
    Petrie C
    Am J Cardiol; 2012 Jul; 110(1):165. PubMed ID: 22704302
    [No Abstract]   [Full Text] [Related]  

  • 7. Peri-operative management of antiplatelet therapy in patients with coronary artery disease: joint position paper by members of the working group on Perioperative Haemostasis of the Society on Thrombosis and Haemostasis Research (GTH), the working group on Perioperative Coagulation of the Austrian Society for Anesthesiology, Resuscitation and Intensive Care (ÖGARI) and the Working Group Thrombosis of the European Society for Cardiology (ESC).
    Korte W; Cattaneo M; Chassot PG; Eichinger S; von Heymann C; Hofmann N; Rickli H; Spannagl M; Ziegler B; Verheugt F; Huber K
    Thromb Haemost; 2011 May; 105(5):743-9. PubMed ID: 21437351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilisation of novel anti-platelet agents: evidence, guidelines and proven patients' value.
    Wallentin L; Himmelmann A; Storey RF; Steg PG; Harrington RA;
    Thromb Haemost; 2014 Jul; 112(1):12-4. PubMed ID: 24816949
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term management of patients with unstable angina and non-ST-elevation MI.
    Banas JS
    J Fam Pract; 2004 Jun; 53(6):451-5. PubMed ID: 15189718
    [No Abstract]   [Full Text] [Related]  

  • 10. New antiplatelet agents: ticlopidine and clopidogrel. Antiplatelet therapy but at what cost?
    Black C; Paterson KR
    Adverse Drug React Toxicol Rev; 2001 Dec; 20(4):277-303. PubMed ID: 11770173
    [No Abstract]   [Full Text] [Related]  

  • 11. Endoscopic procedures in patients under clopidogrel or dual antiplatelet therapy: a survey among German gastroenterologists and current guidelines.
    Abdel Samie A; Theilmann L; Labenz J;
    Z Gastroenterol; 2014 May; 52(5):425-8. PubMed ID: 24824906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiplatelet therapy in the era of percutaneous coronary intervention with drug-eluting balloons.
    Bonaventura K; Sonntag S; Kleber FX
    EuroIntervention; 2011 May; 7 Suppl K():K106-11. PubMed ID: 22027718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guidelines for the management of antiplatelet therapy in patients with coronary stents undergoing non-cardiac surgery.
    Cardiac Society of Australia and New Zealand
    Heart Lung Circ; 2010 Jan; 19(1):2-10. PubMed ID: 20045378
    [No Abstract]   [Full Text] [Related]  

  • 14. Antiplatelet therapy: a vascular medicine perspective.
    Olin JW
    Manag Care; 2000 Oct; 9(10 Suppl):9-12. PubMed ID: 11729422
    [No Abstract]   [Full Text] [Related]  

  • 15. Antiplatelet therapy: a vascular medicine perspective.
    Olin JW
    Manag Care; 2000 May; 9(5 Suppl):11-4. PubMed ID: 11729407
    [No Abstract]   [Full Text] [Related]  

  • 16. Why don't we practice evidence-based medicine?
    Goldberg SL
    J Invasive Cardiol; 2005 Jan; 17(1):8-9. PubMed ID: 15640530
    [No Abstract]   [Full Text] [Related]  

  • 17. [Recommendations for peri-procedural thrombocyte aggregation inhibition].
    Sauer H; Leschke M
    Dtsch Med Wochenschr; 2006 Feb; 131(8):400-2. PubMed ID: 16479474
    [No Abstract]   [Full Text] [Related]  

  • 18. Viewpoint: mismatch between the European and American guidelines on oral antiplatelet P2Y12 inhibitors after acute coronary syndromes.
    Serebruany VL; DiNicolantonio JJ
    Thromb Haemost; 2013 Jul; 110(1):5-10. PubMed ID: 23743577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using clopidogrel bisulfate: a new antiplatelet drug.
    Pfister SM
    Nurse Pract; 1999 Sep; 24(9):100-1, 105-8, 110. PubMed ID: 10507077
    [No Abstract]   [Full Text] [Related]  

  • 20. Clopidogrel: a new antiplatelet agent.
    Feret B
    Conn Med; 1999 Jun; 63(6):331-3. PubMed ID: 10432766
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.